BeiGene Named Manufacturer of the Year by the National Association of Specialty Pharmacy (NASP)
read more...
Oct 21, 2024
BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma
| RegularNews read more...
BeiGene Announces Availability of TEVIMBRA® in U.S.
read more...
Sep 26, 2024
BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA®, for Treatment of ESCC and Gastric/GEJ Cancers
| RegularNews read more...
Sep 26, 2024
Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
| RegularNews read more...
Sep 17, 2024
BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy
| RegularNews read more...
Sep 09, 2024
BeiGene Announces Updates to Commercial Leadership Team
| RegularNews read more...
Sep 09, 2024
BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024
| RegularNews read more...
Aug 28, 2024
BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
| RegularNews read more...
Aug 26, 2024
BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL
| RegularNews read more...
Aug 07, 2024
BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
| RegularNews read more...
Jul 23, 2024
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
| RegularNews read more...
Jul 18, 2024
BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer
| RegularNews read more...
Jun 14, 2024
BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024
| RegularNews read more...
Jun 04, 2024
BeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
| RegularNews read more...
May 24, 2024
BRUKINSA® Data at ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLL
| RegularNews read more...
May 14, 2024
BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024
| RegularNews read more...
May 08, 2024
BeiGene Reports First Quarter 2024 Financial Results and Business Updates
| RegularNews read more...
Apr 26, 2024
BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
| RegularNews read more...
